NCT00521300 - Preoperative Octreotide Treatment of Acromegaly | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

June 30, 2005

Study Completion Date

May 31, 2010

Conditions

Acromegaly

Interventions

DRUG

Octreotide

First week: Octreotide 50 micrograms subcutaneously three times daily. Second week: Octreotide 100 micrograms subcutaneously three times daily. From the third week on: Octreotide LAR 20 mg intramuscularly every 28th day for 6 months

PROCEDURE

Direct surgery for acromegaly

Direct transsphenoidal surgery

Trial Locations (5)

7006

Department of Endocrinology, St. Olavs Hospital, Trondheim

Unknown

Endocrinology Unit, Department of Medicine, Haukeland University Hospital, Bergen

Endocrinology Unit, Department of Medicine, Aker University Hospital, Oslo

Endocrinology Unit, Department of Medicine, Rikshospitalet-Radiumhospitalet Medical Center, Oslo

Endocrinology Unit, Department of Medicine, University Hospital of North Norway, Tromsø